INTEGRATED BIOPHARMA INC Quarterly Operating Income (Loss) in USD from Q3 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Integrated Biopharma Inc quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q1 2024.
  • Integrated Biopharma Inc Operating Income (Loss) for the quarter ending March 31, 2024 was $355K, a 707% increase year-over-year.
  • Integrated Biopharma Inc Operating Income (Loss) for the twelve months ending March 31, 2024 was -$72K, a 115% decline year-over-year.
  • Integrated Biopharma Inc annual Operating Income (Loss) for 2023 was $120K, a 95.6% decline from 2022.
  • Integrated Biopharma Inc annual Operating Income (Loss) for 2022 was $2.75M, a 52.5% decline from 2021.
  • Integrated Biopharma Inc annual Operating Income (Loss) for 2021 was $5.78M, a 77.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$72K $355K +$311K +707% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$383K -$452K -$419K -1270% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-12
Q3 2023 $36K -$54K -$84K -280% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $120K $79K -$359K -82% Apr 1, 2023 Jun 30, 2023 10-K 2023-09-15
Q1 2023 $479K $44K -$948K -95.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $1.43M -$33K -$763K -105% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-12
Q3 2022 $2.19M $30K -$555K -94.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $2.75M $438K -$874K -66.6% Apr 1, 2022 Jun 30, 2022 10-K 2023-09-15
Q1 2022 $3.62M $992K -$727K -42.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $4.35M $730K -$514K -41.3% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 $4.86M $585K -$924K -61.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $5.78M $1.31M +$694K +112% Apr 1, 2021 Jun 30, 2021 10-K 2022-09-13
Q1 2021 $5.09M $1.72M +$759K +79.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $4.33M $1.24M +$39K +3.24% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 $4.29M $1.51M +$1.03M +217% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $3.26M $618K +$43K +7.48% Apr 1, 2020 Jun 30, 2020 10-K 2021-09-02
Q1 2020 $3.22M $960K -$277K -22.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $3.49M $1.21M +$718K +147% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-12
Q3 2019 $2.78M $476K +$71K +17.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $2.7M $575K -$50K -8% Apr 1, 2019 Jun 30, 2019 10-K 2020-09-23
Q1 2019 $2.75M $1.24M +$577K +87.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $2.18M $487K +$289K +146% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-12
Q3 2018 $1.89M $405K +$194K +91.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $1.69M $625K Apr 1, 2018 Jun 30, 2018 10-K 2019-08-29
Q1 2018 $660K +$231K +53.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $198K -$372K -65.3% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-13
Q3 2017 $211K -$1.15M -84.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q1 2017 $429K -$21K -4.67% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $570K +$402K +239% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-09
Q3 2016 $1.36M +$874K +180% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q1 2016 $1.18M $450K +$438K +3650% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $738K $168K -$231K -57.9% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 $969K $485K +$36K +8.02% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $933K $73K -$196K -72.9% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-02
Q1 2015 $1.13M $12K +$208K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $921K $399K -$220K -35.5% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-19
Q3 2014 $1.14M $449K -$211K -32% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $1.35M $269K -$282K -51.2% Apr 1, 2014 Jun 30, 2014 10-K 2015-09-04
Q1 2014 $1.63M -$196K -$361K -219% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $2M $619K +$588K +1897% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 $1.41M $660K +$291K +78.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $1.12M $551K +$1.76M Apr 1, 2013 Jun 30, 2013 10-K 2014-09-08
Q1 2013 -$642K $165K +$593K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$1.24M $31K -$488K -94% Oct 1, 2012 Dec 31, 2012 10-Q/A 2014-02-13
Q3 2012 -$747K $369K -$241K -39.5% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-19
Q2 2012 -$506K -$1.21M -$1.27M -1901% Apr 1, 2012 Jun 30, 2012 10-K 2013-09-30
Q1 2012 $768K -$428K -$71K -19.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 $839K $519K +$639K Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
Q3 2011 $200K $610K +$562K +1171% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q2 2011 -$362K $67K Apr 1, 2011 Jun 30, 2011 10-K 2012-10-15
Q1 2011 -$357K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q4 2010 -$120K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-21
Q3 2010 $48K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.